Related Experiment Videos
[Malaria prophylaxis and treatment: problems, recent developments and perspectives]
B Pradines1, H Vial, P Olliaro
1Unité de Parasitologie, Institut de Médecine Tropicale du Service de Santé des Armées, Bd, Charles Livon, Parc du Pharo, BP 46, 13998 Marseille-Armées, France. bruno.pradines@free.fr
Medecine Tropicale : Revue Du Corps De Sante Colonial
|August 2, 2003
Summary
Antimalarial drug resistance necessitates new treatments. Research explores novel drug targets, including lipid metabolism and hemoglobin degradation, to combat Plasmodium parasites.
Area of Science:
- * Medicinal Chemistry and Parasitology: Focuses on the discovery and development of novel antimalarial compounds.
- * Drug Resistance Mechanisms: Investigates how Plasmodium parasites develop resistance to existing antimalarial drugs.
Context:
- * Rising antimalarial drug resistance poses a significant threat to global malaria control efforts.
- * Existing drug resistance necessitates the urgent development of new therapeutic agents.
- * Malaria control programs face challenges in widespread drug distribution without exacerbating resistance.
Purpose:
- * To explore diverse research avenues for developing new antimalarial drugs.
- * To identify novel molecular targets within the Plasmodium parasite for therapeutic intervention.
- * To expand the arsenal of antimalarial agents available for malaria treatment and prevention.
Summary:
- * Significant resistance to current antimalarials drives the search for new drugs.
- * Research focuses on novel targets such as lipid metabolism, hemoglobin degradation, and apicoplasty.
- * Developing a broader range of antimalarial drugs is crucial for effective malaria control.
Impact:
- * New antimalarial drugs will provide crucial tools to combat drug-resistant malaria strains.
- * A diverse drug pipeline can help malarial control agencies manage drug distribution effectively.
- * Overcoming Plasmodium's evolved defense mechanisms is key to reducing malaria burden.